There will be no public
& Proposals for Election, Stockholder
Fighting Counterfeit Drugs, New Safety
Phone: +49 214 30 1, Mllerstrae 178
Cancer Immunol Res. Arab Emirates, United
access to the materials is prohibited or restricted. and Life in balance, Healthy
The above described license is conditioned on your compliance with these Terms, and shall terminate upon termination of these Terms. Investing in a stronger future - for our shareholders, and
R&D expenses before special items amounted to 5.3 billion euros.
The Week's 10 Biggest Funding Rounds: Monogram And ShiftKey Land Huge This area provides news, videos and publications, as well as overviews of social Media channels and mobile apps of the Bayer Group. These electronic materials are thus extremely vulnerable to unauthorized distribution and copyright infringement. Looking for a job in an innovative company? available on this webpage by Bayer in good faith and for information purposes only. Health, Crop
Please note that Google has its own privacy policies which are independent from ours.
NEXTPOINT THERAPEUTICS, INC. :: Delaware (US) - OpenCorporates NextPoints programs aim to deliver monotherapies for cancer patients without viable treatment options. You may only make a verifiable consumer request for access or data portability twice within a 12-month period. NextPoint originated from the combined expertise of its academic founders, Gordon Freeman, PhD, of the Dana-Farber Cancer Institute, and XingXing Zang, PhD, of Albert Einstein College of Medicine. Stories, Annual
NextPoint Therapeutics Appoints Leena Gandhi, MD, PhD, as Chief Medical This announcement is an advertisement and does not, under any
Kong, China, Ireland,
Development, Test CS
announcements and other documents available in electronic format on this webpage does not constitute
Portal, Countermotions
Supply Chain Management Trainee Program, International
Access to electronic versions of these materials is being made available on this webpage by Bayer in
Drs. focus on the areas of health care and nutrition. PhD or MD in cancer biology, immunology, genomics, biochemistry, or molecular/cellular biologybackground in immunology and immuno-oncology biomarker development strongly preferred. Sanofi Ventures invests in early-stage biotech and digital health companies with innovative ideas and transformative new products and technologies of strategic interest to Sanofi. NextPoint Therapeutics, founded in 2018, reeled in $80 million in equity from 13 investors last month, according to an SEC filing from December. We will respond to reasonable requests as soon as practicable and as required by law. recommendation by Bayer, or any other party to buy or sell securities issued by Bayer.
NextPoint Therapeutics Announces $80 Million Series B Financing co-led Reports, Bayer AG
& Impact, Benefits
Our innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. In most cases, we need to process certain components of your Personal Data in order to fulfill our contractual obligations to you and for our legitimate interests. an offer to the public of the securities has not been made and will not be made in such Relevant
Scott Chappel - Executive Partner at MPM Capital | The Org NEXTPOINT THERAPEUTICS, INC. Company Number 7059407 Incorporation Date 17 September 2018 (over 4 years ago) Company Type Corporation Jurisdiction Delaware (US) Agent Name THE CORPORATION TRUST COMPANY Agent Address CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, New Castle, DE, 19801 Directors / Officers THE CORPORATION TRUST COMPANY, agent for Prescription Medicine in Europe, Counterfeits in
You can use the Easy Apply feature on LinkedIn view job description. HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T cell function. Monsanto, How to
NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. Audit, International
Locations, Your
Angela Poppe Ries, MD, was named chief medical officer of VyncaCare, a home healthcare company for patients living with serious illness. jurisdictions, only certain categories of person may be allowed to view such materials. We use technical and organizational security measures designed to secure and protect Personal Data. The final prospectus, when published, will be
Team, Our
Your computer and mobile devices when you visit our Site. Infringe any third partys copyright, patent, trademark, trade secret or other proprietary rights or rights of publicity or privacy. Bayer, Meet
+49 2173 380. While immune checkpoint inhibitors targeting PD-1/L1 have revolutionized cancer treatments,. Join to view profile NextPoint Therapeutics, Inc. . Among these areas are oncology, immunology, rare diseases, vaccines, potential cures in other core areas of Sanofis business footprint, and digital health solutions. Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. We may update this Privacy Notice from time to time. Please note, however, we cannot fully eliminate security risks associated with the storage and transmission of Personal Data. in the United States, Australia, Canada, South Africa or Japan or any other jurisdiction, where
The support of our new investors along with the continued commitment of our existing investors and founders emphasizes our momentum and progress in defining precision immuno-oncology for new patient segments., Juergen Eckhardt, MD, Head of Leaps by Bayer, commented, Leaps by Bayer was founded to help solve ten of the worlds biggest challenges in health and agriculture, including preventing and curing cancer. Submit material that is intentionally false, defamatory, unlawfully threatening or unlawfully harassing. In other
Africa, Sri
Responsible Lobbying, Climate, Environment and
and Follow-up Questions, How to
NextPoint Therapeutics is an exciting early-stage Boston-area startup company working at the frontier of immuno-oncology. of
Apellis' blindness drug approved by FDA; Moderna strikes gene-editing Alternatively, users can deactivate cookies from third-party providers by going to the network advertising initiatives deactivation page (link:https://optout.networkadvertising.org/?c=1). Nutrition
jurisdictions.
NextPoint Therapeutics, Inc. hiring Associate Director/Director 10+ years of pharmaceutical or biotechnology industry experience or mix of industry and academic experience in oncology or cancer immunotherapy with an emphasis on translational research, clinical biomarkers, and monoclonal antibodies, Proven track record of transitioning biomarkers from the bench to the clinic, Strong knowledge of immuno-oncology and associated biomarker approaches, Technical expertise in IHC, RNAscope, flow cytometry, genetics (including ctDNA), RNA-Seq, NanoString, qPCR and ELISAs, Proven success with filing INDs and supporting clinical trials, Competency with bioinformatic datasets and experience collaborating with bioinformaticians to analyze publicly available datasets, Excellent communication and interpersonal skills, personal integrity, professional manner, and ability to gain respect and develop good working relationships with cross functional personnel at all levels, Ability to balance multiple stakeholders and projects simultaneously, and able to operate with high accountability and under tight deadlines, Forward looking thinker, who actively seeks opportunities and proposes solutions with strong decision-making capability, A collaborator who communicates in an open, clear, complete, timely and consistent manner who listens effectively and invites response and discussion, Direct and run clinical operations and clinical trial launch activities for clinical programs, Manage clinical research organizations, clinical and testing lab vendors, Establish clinical operations infrastructure across the organization, Maintain relationships with Sites and KOLs, Represent NextPoint at Scientific and Investigator Meetings, Stay apprised of current trends in clinical trials research and regulatory landscape, Take responsibility for launch and day-to-day operational management of clinical trials including study sites, Participate in Clinical Vendor Governance and Safety Review Committee Meetings, Design and perform ligand binding assays in multi-well formats to analyze novel antibody therapeutics, Develop and execute functional assays involving primary human immune cells, mammalian cell culture, and multi-color flow cytometry to screen novel antibody therapeutics in an immune-oncology setting, Work independently to design and conduct experiments, analyze, interpret, and communicate data in team meetings and to leadership, Support the laboratory organization and operations by maintaining lab equipment and managing reagent and supply inventories, Bachelors degree in cell/molecular biology, immunology, or cancer biology or equivalent field, 2 + years hands-on experience in drug discovery research preferably in an industry setting, Experience with cell-based functional immune assays such as MLR, immune cell activity assays, and cytokine release assays, Experience with multiparameter flow cytometry, Hands on experience with murine tumor models preferred, Excellent verbal and written communication skills with a demonstrated ability to work collaboratively and thrive in a team environment, Excellent interpersonal skills and willingness to learn a variety of new techniques and technologies; flexibility to adapt to rapidly changing priorities and deadlines. our employees, International
2003/71/EC, and any amendments thereto (the Prospectus Directive)(each a Relevant Member State),
Some cookies and other technologies may serve to track Personal Data previously entered by a web user on our site. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Leaps by Bayer and Sanofi Ventures co-led the round and were joined . Our innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. expression Prospectus Directive includes any relevant implementing measure in each Relevant Member
Settings. Republic, El
Bar on Crop Protection Safety Standards, UN
Services & Downloads, AGM
Bayer Global
Reporting to the Chief Medical Officer, the Vice President will build our Translational Medicine capability, responsible for managing research activities bridging from discovery to clinical development. Phone:
At Regulus Therapeutics, he led the fibrosis and the platform groups that contributed to advancing multiple microRNA-based programs into the clinic. Protection, Environmental
States, Australia, Canada or Japan. offering or an invitation to the public in connection with any offer within the meaning of
NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi. Worldwide, News &
Contact Us - Nextpoint NextPoint Therapeutics Announces $80 Million Series B Financing co-led COVID19 vaccination required for onsite work; Exemptions for religious or medical reasons should reach out to HR for accommodations. We will also retain your Personal Data as necessary to comply with our legal obligations, resolve disputes, and enforce our agreements. NextPoint Therapeutics, $80M, biotech: Cambridge, Massachusetts-based NextPoint Therapeutics, a biotechnology company involved in immuno-oncology, raised an $80 million Series B co-led by Leaps by Bayer and Sanofi Ventures. Drs. State by any measure implementing the Prospectus Directive in that Relevant Member State, and the
The candidate will collaborate with Research and Clinical Development to develop and refine NextPoints clinical translational strategy and drive its effective implementation to support our clinical programs. Viewing the materials you seek to access may not be lawful in certain jurisdictions. offer of the securities in any jurisdiction. Furthermore, where permissible, we may charge for this service. In fiscal 2021, the Group employed around 100,000 people and had sales of 44.1 billion euros. 4. This time around, we note that NextPoint Therapeutics hired Leena Gandhi as chief medical officer. 13353 Berlin
Australia, Canada, South Africa or Japan or any other jurisdiction, where access to the materials is
Scoop: MPM backs a new checkpoint inhibitor biotech in $80M raise Higher wind gusts possible.. Phone: +49 30 468 1111, Alfred-Nobel-Str. Water
relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. Republic of, New
For more information. 2013 Jun 11;110(24):9879-84. NextPoints outstanding team of scientists who have characterized the HHLA2 pathway along with experienced drug developers in the management team makes for the ideal chemistry to usher these novel immuno-oncology programs into the clinic.. Access to electronic versions of these materials is being made
Plentiful sunshine. Governance, Board of
NEXTPOINT EXPRESSLY DISCLAIMS: (i) ALL WARRANTIES, EXPRESS OR IMPLIED, INCLUDING ANY IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE; (ii) ANY RESPONSIBILITY OR LIABILITY FOR THE ACCURACY, CONTENT, COMPLETENESS OR LEGALITY OF INFORMATION AVAILABLE THROUGH THE WEBSITE; AND (iii) ANY RESPONSIBILITY OR LIABILITY FOR HARM RESULTING FROM DOWNLOADING OR ACCESSING INFORMATION THROUGH THE WEBSITE, INCLUDING HARM CAUSED BY VIRUSES OR SIMILAR DESTRUCTIVE FEATURES. Proc Natl Acad Sci U S A. and Social Needs, Bayer and
25. The company assumes no liability whatsoever to update these forward-looking statements or to conform, Deutsch
Sec Form D Innovations, Redefining
This announcement does not contain or constitute an offer of, or the solicitation of an offer to
Headquarters, Costa
To analyze and improve our Services, administer our Site and Services, provide you with access to our Services, analyze and improve our information technology, monitor compliance with our Terms of Use, and enforce our Terms of Use or other legal or regulatory obligations, Geolocation Data such as physical location information that may be provided by the device you are using. Statements, Questions
High 61F. They are all working on potentially breakthrough technologies to overcome some specific challenges such as, e.g., developing a sustainable protein supply, reducing the environmental impact of agriculture, preventing or curing cancer, and others. NextPoint does not sell your Personal Information. The combined expertise and research of XingXing Zang, PhD (Albert Einstein College of Medicine) and Gordon Freeman, PhD (Dana-Farber Cancer Institute) form the basis of NextPoint Therapeutics. in the United States absent registration or an applicable exemption from the registration
restricted. Germany
Bayers leadership in agriculture provides tailored solutions
If you breach any provision of these Terms, any license you have obtained will be automatically rescinded and terminated. Distances, Work
amended (the "U.S. Securities Act"), or any U.S. State security laws and may not be offered or sold
HR Trainee Program, International
Protection Products & Seeds, Supplier
In fiscal 2021, the Group employed around 100,000 people and had sales of 44.1 billion euros. Clin Cancer Res. Zealand, Palestinian
Press release content from Business Wire. Fraudulent Brands, Commitment to
As #AI becomes more powerful and widespread, how can we harness these new technologies to improve human health? The online community has not agreed on what actions, if any, should be taken by the websites that receive the do not track signal, and therefore Do-Not-Track is not yet standardized. By using any portion of the Site, you acknowledge and consent to the transfer of your information to our facilities in the United States. for a hungry planet, Bayer
Rankings, Vision &
the Market, Pharmaceutical
Nextpoint Therapeutics, Inc. Company Profile | Cambridge, MA at
+49 30 468 1111, Alfred-Nobel-Str. I agree to be bound by its terms. She completed postgraduate training at Massachusetts General Hospital and at Dana-Farber Cancer Institute in Boston. available in electronic format on this webpage does not constitute an offer to sell or the
Making press
Breakpoint Therapeutics' mission is to develop first- and best-in-class oncology drugs that interfere with DNA repair and replication stress pathways to facilitate the cure of . This laboratory-based role will work across our emerging portfolio to ensure the efficient execution of multiple therapeutic programs. Emirates, Nubeqa (darolutamide) receives EU approval for additional indication in prostate cancer, Bayer submits aflibercept 8 mg for marketing authorization in Japan, Recording of the Financial News Conference on the Full Year 2022 Results (partly dubbed into English), Bayer: Significant growth in sales and earnings, Photos from the Financial News Conference, Financial News Conference on the Full Year 2022 Results, Consumer